STOCK TITAN

Prenetics to Participate in the 37th Annual ROTH Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Prenetics Global (NASDAQ: PRE), a leading consumer health sciences company, has announced its participation in the 37th Annual ROTH Conference. The event will take place from March 16th to March 18th, 2025, at the Laguna Cliffs Marriott Resort in Dana Point, CA.

CEO Danny Yeung and President of Americas David Vanderveen will be available for one-on-one meetings with investors. Additionally, management will join a panel discussion focused on Longevity and Supplementation on Monday, March 17th at 12:00pm PT. The panel discussion will be accessible via webcast and will be available on Prenetics' investor relations website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

-2.73%
1 alert
-2.73% News Effect

On the day this news was published, PRE declined 2.73%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

CHARLOTTE, N.C., March 11, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading consumer health sciences company, announced today the Company will participate in the 37th Annual ROTH Conference being held Sunday, March 16th to Tuesday, March 18th at the Laguna Cliffs Marriott Resort in Dana Point, CA.

Prenetics’ Chief Executive Officer Danny Yeung and President of Americas David Vanderveen will be available to host one-on-one meetings with investors during the event. In addition, management will participate in a panel discussion on Longevity and Supplementation on Monday, March 17th at 12:00pm PT. Interested parties may access the panel through the webcast link here which will also be posted to Prenetics’ investor relations website here.

To schedule a one-on-one meeting with Prenetics’ management, please contact Investor Relations at PRE@mzgroup.us or your ROTH representative.

About Prenetics

Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer and clinical health. Our consumer initiative is led by IM8, a new health and wellness brand, and Europa, one of the largest sports distribution companies in the USA. Our clinical division is led by Insighta, our $200 million venture focused on multi-cancer early detection technologies. Each of Prenetics’ units synergistically enhances our global impact on health, embodying our commitment to ‘enhancing life through science’. To learn more about Prenetics, please visit prenetics.com.

Investor Relations Contact:
investors@prenetics.com
PRE@mzgroup.us

Angela Cheung
Investor Relations / Corporate Finance
Prenetics Global Limited
angela.hm.cheung@prenetics.com


FAQ

When and where is Prenetics (PRE) participating in the ROTH Conference 2025?

Prenetics will participate in the 37th Annual ROTH Conference from March 16-18, 2025, at the Laguna Cliffs Marriott Resort in Dana Point, CA.

What panel discussion will Prenetics (PRE) participate in at the ROTH Conference?

Prenetics management will participate in a Longevity and Supplementation panel discussion on Monday, March 17th at 12:00pm PT.

How can investors meet with Prenetics (PRE) management at the ROTH Conference?

Investors can schedule one-on-one meetings with management by contacting Investor Relations at PRE@mzgroup.us or through their ROTH representative.

How can investors access Prenetics' (PRE) panel discussion at the ROTH Conference?

Investors can access the panel discussion through a webcast link available on Prenetics' investor relations website.
Prenetics Ltd

NASDAQ:PRE

PRE Rankings

PRE Latest News

PRE Latest SEC Filings

PRE Stock Data

360.13M
14.55M
19.88%
12.67%
0.48%
Diagnostics & Research
Accident & Health Insurance
Link
Hong Kong
PEMBROKE